Author:
Carlini E. A.,Maia Lucas O.
Reference57 articles.
1. Addington J. The diagnosis and assessment of individuals prodromal for schizophrenic psychosis. CNS Spectr. 2004;9(8):588–94.
2. Alper KR, Lotsof HS, Kaplan CD. The ibogaine medical subculture. J Ethnopharmacol. 2008;115(1):9–24.
3. Bravo GL, Grob CS. Hallucinogens - What’s In a Name? or Defending The Indefensible. MAPS Bulletin. Spring 2003;13(1):55–56. http://www.maps.org/news-letters/v13n1/v13n1_55-56.pdf
4. Brown JH, Laiken N. Agonistas e antagonistas dos receptores muscarínicos. In: Brunton LL, Chabner BA, Knollmann BC, (Orgs.). As bases farmacológicas da terapêutica de Goodman & Gilman’s. AMGH Editora: Rio de Janeiro; 2012.
5. Callaway JC, Grob CS. Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions. J Psychoactive Drugs. 1998;30(4):367–9.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献